Megan Messerly, Nevada Independent
A federal court judge Tuesday denied a request by pharmaceutical industry representatives to preliminarily enjoin Nevada’s first-in-the-nation insulin transparency law, rejecting arguments that the law would cause immediate and irreparable harm to manufacturers of diabetes drugs.
Go here for the full story.
